Western blot analyses further demonstrated upregulation of pro-apoptotic molecules, including Caspase-7, Caspase-3, and Bax, along with downregulation of anti-apoptotic Bcl-2, suggesting enhanced tumor cell apoptosis as a key mechanism driving therapeutic efficacy. The gene discussed is CASP3; the disease is neoplasm.